|
1.Coresh J, BC. A, G. GT, L. A. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis, 2003, pp 1-12. 2.WW. B, RM. P, SE. O, WF. K, A. C, SC. C, et al. Early detection of kidney disease in community settings: the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 2003; 2003. 3.Warnock DG, McClellan W, McClure LA, Newsome B, Campbell RC, Audhya P, et al. Prevalence of chronic kidney disease and anemia among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study:baseline results. Kidney Int 2005; 68: 1427-1431. 4.Hwang SJ, Tsai JC, Chen HC. Epidemiology, impact and preventive care of chronic kidney disease in Taiwan. Nephrology (Carlton); 15 Suppl 2: 3-9. 5.Kopple JD. Nutritional therapy in kidney failure. Nutr Rev 1981; 39: 193-206. 6.Murphree DD, Thelen SM. Chronic kidney disease in primary care. J Am Board Fam Med; 23: 542-550. 7.Castaneda C, Gordon PL, Parker RC, Uhlin KL, Roubenoff R, Levey AS. Resistance training to reduce the malnutrition-inflammation complex syndrome of chronic kidney disease. Am J Kidney Dis 2004; 43: 607-616. 8.Kalender B, Ozdemir AC, Dervisoglu E, Ozdemir O. Quality of life in chronic kidney disease: effects of treatment modality, depression, malnutrition and inflammation. Int J Clin Pract 2007; 61: 569-576. 9.Mitch WE. Proteolytic mechanisms, not malnutrition, cause loss of muscle mass in kidney failure. J Ren Nutr 2006; 16: 208-211. 10.Mitch WE. Malnutrition is an unusual cause of decreased muscle mass in chronic kidney disease. J Ren Nutr 2007; 17: 66-69. 11.Wiggins KL, Harvey KS. A review of guidelines for nutrition care of renal patients. J Ren Nutr 2002; 12: 190-196. 12.Foundation FNK. Clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis 2002: 39:s19. 13.尹彙文, 陳淑娟. 臨床營養學-膳食療養. 明新出版有限公司, 2005, pp 409-410. 14.MH R, J BW. Core curriculum in nephrology. Renal function testing. . Kidney Dis 2006; 47: 174-183. 15.Group KDGW. K/DOQI clinical practice guidelines for chronic kidney diseade: Evidence, classification and stratification. Am J Kidney Dis 2002: 39:S103-109. 16.K/DOQI KDGWG. K/DOQI Clinical practice guideline for chronic kidney disease: evaluation, classification, and stratification. Am J kidney Dis 2002; 39(supp1). 17.Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, et al. The metabolic syndrome. Endocr Rev 2008; 29: 777-822. 18.Levesque J, Lamarche B. The metabolic syndrome: definitions, prevalence and management. J Nutrigenet Nutrigenomics 2008; 1: 100-108. 19.Mota M, Panus C, Mota E, Lichiardopol C, Vladu D, Toma E. The metabolic syndrome--a multifaced disease. Rom J Intern Med 2004; 42: 247-255. 20.Scheen AJ. Management of the metabolic syndrome. Minerva Endocrinol 2004; 29: 31-45. 21.Spinler SA. Challenges associated with metabolic syndrome. Pharmacotherapy 2006; 26: 209S-217S. 22.Samuelsson O, Attman PO. Is smoking a risk factor for progression of chronic renal failure? Kidney Int 2000; 58: 2597. 23.Orth SR, Odoni G, Ogata H, Ritz E. Smoking as a risk factor for end-stage renal failure in patients with primary renal disease. Contrib Nephrol 2000; 130: 109-123. 24.Orth SR, Stockmann A, Conradt C, Ritz E, Ferro M, Kreusser W, et al. Smoking as a risk factor for end-stage renal failure in men with primary renal disease. Kidney Int 1998; 54: 926-931. 25.Ukena C, Mahfoud F, Kindermann M, Graber S, Kindermann I, Schneider M, et al. Smoking is associated with a high prevalence of microalbuminuria in hypertensive high-risk patients: data from I-SEARCH. Clin Res Cardiol. 26.Fischer MJ, O''Hare AM. Epidemiology of hypertension in the elderly with chronic kidney disease. Adv Chronic Kidney Dis; 17: 329-340. 27.Stevens LA, Viswanathan G, Weiner DE. Chronic kidney disease and end-stage renal disease in the elderly population: current prevalence, future projections, and clinical significance. Adv Chronic Kidney Dis; 17: 293-301. 28.Kuroki A, Akizawa T. [Management of chronic kidney disease--preventing the progression of renal disease]. Nippon Rinsho 2008; 66: 1735-1740. 29.Katchunga P, Hermans MP, Manwa B, Lepira F, Kashongwe Z, M''Buyamba-Kabangu JR. [Hypertension, insulin resistance and chronic kidney disease in type 2 diabetes patients from South Kivu, DR Congo.]. Nephrol Ther. 30.Patel SS, Kimmel PL, Singh A. New clinical practice guidelines for chronic kidney disease: a framework for K/DOQI. Semin Nephrol 2002; 22: 449-458. 31.Jerums G, Premaratne E, Panagiotopoulos S, Clarke S, Power DA, MacIsaac RJ. New and old markers of progression of diabetic nephropathy. Diabetes Res Clin Pract 2008; 82 Suppl 1: S30-37. 32.Soldatos G, Cooper ME. Diabetic nephropathy: important pathophysiologic mechanisms. Diabetes Res Clin Pract 2008; 82 Suppl 1: S75-79. 33.Woredekal Y. Early detection and treatment of diabetic nephropathy. Pediatr Endocrinol Rev 2008; 5 Suppl 4: 999-1004. 34.Foundation. Nk. Kidney Disease Outcomes Quality Initiative, Clinical Practice Guidelines for Nutrition in Chronic Renal Failure. I. Adult guidelines. B. Advanced chronic renal failure without dialysis. Am J Kidney Dis 2000; 35: S56-S65. 35.Kopple JD. National kidney foundation K/DOQI clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis 2001; 37: S66-70. 36.Engel B. Renal dietitians: setting standards in care. EDTNA ERCA J 1997; 23: 13-15. 37.McCarthy M. The chronic kidney disease epidemic: nutrition intervention and control. Nephrol Nurs J 2004; 31: 83-84. 38.Stall S. Protein recommendations for individuals with CKD stages 1-4. Nephrol Nurs J 2008; 35: 279-282. 39.Beto JA, Bansal VK. Medical nutrition therapy in chronic kidney failure: integrating clinical practice guidelines. J Am Diet Assoc 2004; 104: 404-409. 40.Appel LJ MT, Obarzanek E. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997; 336. 41.Bakris GL WM. Salt intake and reductions in arterial pressure and proteinuria: Is there a direct link? Am J Hypertens 1996; 9: 200S-206S. 42.(U.S.) IoM. Panel on Dietary Reference Intakes for Electrolytes and Water: Dietary reference intakes for water, potassium, sodium, chloride and sulfate. In Ch xviii Washington, DC, National Academies Press 2005; 617. 43.Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344: 3-10. 44.Nakagawa T, Mazzali M, Kang DH, Sanchez-Lozada LG, Herrera-Acosta J, Johnson RJ. Uric acid--a uremic toxin? Blood Purif 2006; 24: 67-70. 45.Kang DH, Nakagawa T. Uric acid and chronic renal disease: possible implication of hyperuricemia on progression of renal disease. Semin Nephrol 2005; 25: 43-49. 46.Johnson RJ, Kivlighn SD, Kim YG, Suga S, Fogo AB. Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease. Am J Kidney Dis 1999; 33: 225-234. 47.Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003; 41: 1183-1190. 48.Feig DI, Mazzali M, Kang DH, Nakagawa T, Price K, Kannelis J, et al. Serum uric acid: a risk factor and a target for treatment? J Am Soc Nephrol 2006; 17: S69-73. 49.Feig DI, Kang DH, Nakagawa T, Mazzali M, Johnson RJ. Uric acid and hypertension. Curr Hypertens Rep 2006; 8: 111-115. 50.Feig DI. Uric acid: a novel mediator and marker of risk in chronic kidney disease? Curr Opin Nephrol Hypertens 2009; 18: 526-530. 51.Edwards NL. The role of hyperuricemia and gout in kidney and cardiovascular disease. Cleve Clin J Med 2008; 75 Suppl 5: S13-16. 52.Beguiristain MA, Garda EA. [Nutrition in gout. Purine-free and low-purine diet.]. Sem Med 1961; 119: 305-313. 53.Robinson CH. The low purine diet. Am J Clin Nutr 1954; 2: 276-277. 54.Stevens LA, Li S, Wang C, Huang C, Becker BN, Bomback AS, et al. Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis; 55: S23-33. 55.Shinaberger CS, Greenland S, Kopple JD, Van Wyck D, Mehrotra R, Kovesdy CP, et al. Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr 2008; 88: 1511-1518. 56.Negri AL. [K-DOQI guidelines for calcium and phosphorus metabolism in chronic kidney disease: outcomes, compliance and new drugs for treatment]. Nefrologia 2007; 27: 670-673. 57.Foundation. Nk, Initiative. KDOQ. Clinical Practice Guidelines for Nutrition in Chronic Renal Failure. I. Adult guidelines. B. Advanced chronic renal failure without dialysis. Am J Kidney Dis 2000; 2000: suppl.2:S56-S65.
|